The Hizentra app–your infusion log is never farther away than your phone!

Stay on track with your therapy and keep a clear record of your infusion history to help manage your treatment needs. Regularly tracking your infusions gives you the power to share your treatment history and improve conversations with your doctor around the best dosing and infusion schedule for you!

Schedule infusion reminders based on the treatment plan created with your doctor Hizentra app infusion schedule sample

Scan your Hizentra label at the start of your infusion to auto-populate the lot number and expiration date Hizentra app record infusion sample

Track your infusion details, including dosage, time, and which infusion sites were used Hizentra app infusion details sample

Share your infusion history, via email or in person, with your doctor to help monitor your therapy and personalize treatment to your specific needs Hizentra app infusion journal sample

Explore links to other resources and support, including training videos and a self-infusion guide Hizentra app infusion sample

Apple, the Apple logo, iPad, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. By clicking on the App Store link above, you will be taken to a website hosted by Apple.

Android and Google Play are trademarks of Google Inc. By clicking on the Google Play link above, you will be taken to a site hosted by Google Inc.

For technical help with the app, please contact HizentraAppUS@csldigitalsupport.com

If you currently use the MyHizentra® Infusion Manager app, you will be transferred to the new Hizentra app during regular app updates. Upon launching the new app, current MyHizentra® Infusion Manager app users will be asked to confirm their profile so it can be migrated seamlessly into the new app.

View information about Hizentra for:

CIDP

chronic inflammatory demyelinating polyneuropathy

PI

primary immunodeficiency


acuity
You are now leaving the current website.

Do you want to continue?

No Yes